{"id":"NCT00525824","sponsor":"AstraZeneca","briefTitle":"12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe","officialTitle":"A 12-week Open-label, Randomised, Parallel-group, Multicentre, Phase IIIb Study to Compare the Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe and Simvastatin in Patients With Hypercholesterolaemia and CHD","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2007-08","primaryCompletion":"2008-09","completion":"2008-09","firstPosted":"2007-09-06","resultsPosted":"2009-10-07","lastUpdate":"2011-05-13"},"enrollment":1743,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Hypercholesterolemia","Coronary Heart Disease","Atherosclerosis"],"interventions":[{"type":"DRUG","name":"Rosuvastatin (Crestor)","otherNames":[]},{"type":"DRUG","name":"Ezetimibe","otherNames":[]},{"type":"DRUG","name":"Simvastatin","otherNames":[]}],"arms":[],"summary":"The purpose of this study is to determine whether treatment of Rosuvastatin (CRESTOR™) or Simvastatin given as monotherapy or given in combination with Ezetimibe, will lower the Low Density Lipoprotein Cholesterol (LDL-C) in patients with Hypercholesterolaemia and Coronary Heart Disease (CHD) or a CHD Risk Equivalent, Atherosclerosis or a 10-year CHD Risk of \\>20%","primaryOutcome":{"measure":"Percent Change From Baseline in Low-density Lipoprotein Cholesterol (LDL-C) After 6 Weeks Combination Treatment","timeFrame":"Mean of Weeks 4 and 6 on combination therapy (Last observation carried forward)","effectByArm":[{"arm":"R10 to R10 + E10","deltaMin":-59.72,"sd":14.166},{"arm":"R20 to R20 + E10","deltaMin":-63.48,"sd":16.697},{"arm":"S40 to S40 + E10","deltaMin":-55.22,"sd":15.75},{"arm":"S80 to S80 + E10","deltaMin":-57.42,"sd":20.466}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":2},"locations":{"siteCount":9,"countries":["United States","Argentina","Brazil","Chile","Colombia","Lithuania","Netherlands","Peru","Venezuela"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":3},"commonTop":["Myalgia","Nasopharyngitis","Headache","Arthralgia","Nausea"]}}